Yellow fever - PubMed

Review

Yellow fever

Thomas P Monath et al. J Clin Virol. 2015 Mar.

Abstract

Yellow fever, a mosquito-borne flavivirus disease occurs in tropical areas of South America and Africa. It is a disease of major historical importance, but remains a threat to travelers to and residents of endemic areas despite the availability of an effective vaccine for nearly 70 years. An important aspect is the receptivity of many non-endemic areas to introduction and spread of yellow fever. This paper reviews the clinical aspects, pathogenesis, and epidemiology of yellow fever, with an emphasis on recent changes in the distribution and incidence of the disease. Recent knowledge about yellow fever 17D vaccine mechanism of action and safety are discussed.

Keywords: Epidemiology; Pathogenesis; Yellow fever.

Similar articles

• Yellow fever: an update.

  Monath TP. Monath TP. Lancet Infect Dis. 2001 Aug;1(1):11-20. doi: 10.1016/S1473-3099(01)00016-0. Lancet Infect Dis. 2001. PMID: 11871403 Review.

• Yellow fever vaccines and international travelers.

  Barnett ED, Wilder-Smith A, Wilson ME. Barnett ED, et al. Expert Rev Vaccines. 2008 Jul;7(5):579-87. doi: 10.1586/14760584.7.5.579. Expert Rev Vaccines. 2008. PMID: 18564013 Review.

• Prevention of yellow fever in persons traveling to the tropics.

  Monath TP, Cetron MS. Monath TP, et al. Clin Infect Dis. 2002 May 15;34(10):1369-78. doi: 10.1086/340104. Epub 2002 Apr 25. Clin Infect Dis. 2002. PMID: 11981733 Review.

• Yellow fever: the recurring plague.

  Tomori O. Tomori O. Crit Rev Clin Lab Sci. 2004;41(4):391-427. doi: 10.1080/10408360490497474. Crit Rev Clin Lab Sci. 2004. PMID: 15487593 Review.

• Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  Staples JE, Gershman M, Fischer M; Centers for Disease Control and Prevention (CDC). Staples JE, et al. MMWR Recomm Rep. 2010 Jul 30;59(RR-7):1-27. MMWR Recomm Rep. 2010. PMID: 20671663

Cited by

• The interplay between environmental factors, vector competence and vaccine immunodynamics as possible explanation of the 2019 yellow fever re-emergence in Nigeria.

  Abdullahi IN, Anka AU, Emeribe AU, Umar K, Adekola HA, Uzairue L, Ghmaba PE, Okwume CC. Abdullahi IN, et al. New Microbes New Infect. 2021 Feb 27;41:100858. doi: 10.1016/j.nmni.2021.100858. eCollection 2021 May. New Microbes New Infect. 2021. PMID: 33912348 Free PMC article. Review.

• A safer cell-based yellow fever live attenuated vaccine protects mice against YFV infection.

  Guo W, Jiang T, Rao J, Zhang Z, Zhang X, Su J, Yin C, Lu M, Hu X, Shan C. Guo W, et al. iScience. 2024 Sep 17;27(10):110972. doi: 10.1016/j.isci.2024.110972. eCollection 2024 Oct 18. iScience. 2024. PMID: 39398246 Free PMC article.

• Risk assessment of urban yellow fever virus transmission in Kenya: is Aedes aegypti an efficient vector?

  Agha SB, Tchouassi DP, Turell MJ, Bastos ADS, Sang R. Agha SB, et al. Emerg Microbes Infect. 2022 Dec;11(1):1272-1280. doi: 10.1080/22221751.2022.2063762. Emerg Microbes Infect. 2022. PMID: 35387573 Free PMC article.

• Molecular Characterization of Hamster-Adapted Yellow Fever Virus.

  McArthur MA, Zhang SL, Li L, Tesh RB, Barrett ADT. McArthur MA, et al. Vector Borne Zoonotic Dis. 2020 Mar;20(3):222-227. doi: 10.1089/vbz.2019.2495. Epub 2019 Dec 2. Vector Borne Zoonotic Dis. 2020. PMID: 31794691 Free PMC article.

• Risk of yellow fever virus importation into the United States from Brazil, outbreak years 2016-2017 and 2017-2018.

  Dorigatti I, Morrison S, Donnelly CA, Garske T, Bowden S, Grills A. Dorigatti I, et al. Sci Rep. 2019 Dec 31;9(1):20420. doi: 10.1038/s41598-019-56521-9. Sci Rep. 2019. PMID: 31892703 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science